The Drug-Induced Respiratory Disease Website

V - Myocarditis

V.a

Myocarditis (can be fulminate/fulminant)

1

Evidence level

low

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

1

Evidence level

low

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)

1

Evidence level

low

XXIII - Hemoglobinopathies (acquired, reversible)

XXIII.a

Methemoglobinemia

1

Evidence level

low

XXIII.g

Sulfhemoglobinemia

1

Evidence level

low

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

1

Evidence level

low

XXIV.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

2

Evidence level

possible

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f

Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)

5

Evidence level

definite